Part of our mission is to impact the most people possible with the benefits of infrared. From improved quality of life, to better performance, faster recovery, and more restful sleep, we believe there are endless communities around the world who can benefit from CELLIANT®.
That’s why we are so proud to announce that our regulatory status now reaches over 50 countries, making CELLIANT an ideal global partner.
As our co-founder and CEO, Seth Casden puts it, “We’ve laid the groundwork for our partner brands to capitalize on the benefits of our infrared technology and to enhance their ability to do business. We firmly believe that regulatory status matters and that is why we have grown the number of countries we have such relationships with by over a third in the last three years. It is definitely a competitive advantage of our company and CELLIANT.”
Our growth in regulatory status is also an indication of our commitment to science. We have a Science Advisory Board composed of experts in the fields of photobiology, nanotechnology, sleep medicine, diabetes and wound care that have overseen 9 peer-reviewed published studies and our rigorous testing methods, collectively demonstrating CELLIANT’s effectiveness and the benefits of infrared energy. These studies form the basis of our ability to partner with global regulatory bodies to allow our brand partners to make infrared (IR) benefit claims.
CELLIANT has recently celebrated our 20th anniversary and the growth in regulatory status has been steady and in step with the growth of our team globally. We now have offices on 4 continents with 9 global sales support employees and 10 different legal and regulatory firms. CELLIANT is determined or designated as a Class 1 medical device in 38 countries and cleared to market in a further 15 countries.
Our global growth has led to some great products with brand partners around the world, including:
CELLIANT is determined or designated as a Class 1 medical device in 38 countries:
CELLIANT is cleared to market in 15 countries:
For our purposes, cleared to market means that, based on research in a specific country or region, the evidence supports a conclusion that CELLIANT products and the proposed claims fall outside of the definition of a medical device and no medical device registration is required. In other words, independent assessments have been made that permit certain CELLIANT claims to be made as a non-medical device.
If you’d like to learn more about incorporating CELLIANT into your textile products and how they can help differentiate your brand, please fill out the form below – we would love to hear from you.
December 19, 2024 – The countdown is on for Heimtextil 2025! The world’s premier trade fair for home and contract textiles will take place January 14–17, 2025 in Frankfurt, Germany…
November 25, 2024 – As the world’s most influential tech event, CES 2025 is the ultimate stage for unveiling groundbreaking innovations that shape our future…
November 12, 2024 – LongevityFest 2024, hosted by the American Academy of Anti-Aging Medicine (A4M), is set to take place from December 13 to 15, 2024, at the Venetian Convention Center in Las Vegas. This premier event brings together leading experts, researchers, and innovators…
REQUEST INFORMATION